Lipoprotein(a) further increases the risk of coronary events in men with high global cardiovascular risk
- 6 February 2001
- journal article
- Published by Elsevier
- Vol. 37 (2) , 434-439
- https://doi.org/10.1016/s0735-1097(00)01126-8
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Coronary Heart Disease: Reducing The RiskCirculation, 1999
- Assessment of Cardiovascular Risk by Use of Multiple-Risk-Factor Assessment EquationsCirculation, 1999
- Evaluating Novel Cardiovascular Risk Factors: Can We Better Predict Heart Attacks?Annals of Internal Medicine, 1999
- Lipoprotein(a)Current Opinion in Lipidology, 1999
- Genetic architecture and evolution of the lipoprotein(a) traitCurrent Opinion in Lipidology, 1999
- Lp(a) lipoprotein level predicts survival and major coronary events in the Scandinavian Simvastatin Survival StudyClinical Genetics, 1997
- Hypertriglyceridemia and elevated lipoprotein (a) are risk factors for major coronary events in middle-aged menThe American Journal of Cardiology, 1996
- Lipoprotein Lp(a) as predictor of myocardial infarction in comparison to fibrinogen, LDL cholesterol and other risk factors: results from the prospective Göttingen Risk Incidence and Prevalence Study (GRIPS)European Journal of Clinical Investigation, 1994
- Lipoprotein(a) Levels and Risk of Coronary Heart Disease in MenJAMA, 1994
- Lipoprotein (a) and coronary heart disease: a prospective case-control study in a general population sample of middle aged men.BMJ, 1990